Størstedelen af bivirkningerne var milde til moderate og startede som regel tidligt i behandlingen og forsvandt for det meste ved fortsat behandling.
However, the majority of common adverse drug reactions were mild to moderate, they usually start early in therapy, and most tended to disappear even as therapy was continued.